Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept

NCT00927069 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: Adalimumab every other week
DRUG: Adalimumab Every Week

Sponsor

Innovaderm Research Inc.

Collaborators

[object Object]